# OnCo record influenza-antiviral-prophylaxis-and-early-treatment (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/influenza-antiviral-prophylaxis-and-early-treatment/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "influenza-antiviral-prophylaxis-and-early-treatment" ;
  schema:name "Influenza during cancer treatment: antiviral prophylaxis after exposure and early treatment"@en ;
  schema:alternateName "flu during chemotherapy"@en, "oseltamivir prophylaxis"@en, "Tamiflu after exposure"@en, "post-exposure prophylaxis for influenza"@en, "influenza chemoprophylaxis"@en, "flu antivirals in immunocompromised patients"@en, "baloxavir"@en, "neuraminidase inhibitors"@en ;
  schema:description "Flu is more likely to become serious when cancer or its treatment has weakened the immune system. Antiviral medicines such as oseltamivir are meant to be started early, within 48 hours of the first symptoms or of close contact with flu. The NHS says to get urgent advice if you have flu symptoms and a weakened immune system. Tell your cancer team promptly if someone at home has flu."@en ;
  schema:url <https://onco.cc/protocols/influenza-antiviral-prophylaxis-and-early-treatment/> ;
  schema:dateModified "2026-11-17"^^xsd:date ;
  onco:related <https://onco.cc/protocols/herpes-simplex-and-zoster-antiviral-prophylaxis/>, <https://onco.cc/protocols/vaccination-around-cancer-treatment/>, <https://onco.cc/protocols/neutropenic-precautions-and-daily-life/>, <https://onco.cc/protocols/hand-hygiene-in-cancer-care/>, <https://onco.cc/protocols/febrile-neutropenia-first-hour/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/> .
